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Abstract
Background
Periprosthetic joint infections (PJIs) are dreaded complications of total joint arthroplasties.
The risk of developing PJIs is likely to be influenced by several patient factors such as
sociodemographic characteristics, body mass index (BMI), and medical and surgical histo-
ries. However, the nature and magnitude of the long-term longitudinal associations between
these patient-related factors and risk of developing PJIs are uncertain.
Objective
To conduct a systematic review and meta-analysis to assess the associations between sev-
eral patient-related factors and PJI.
Data Sources
MEDLINE, EMBASE, Web of Science, Cochrane Library, and reference lists of relevant
studies from inception to September 2015.
Study Selection
Longitudinal studies with at least one-year of follow-up for PJIs after total joint arthroplasty.
Data Extraction and Synthesis
Two investigators extracted data on study characteristics, methods, and outcomes. A con-
sensus was reached with involvement of a third. The relative risk (RR) with 95% confidence
intervals was used as the summary measure of association across studies. Study-specific
RRs with 95% confidence intervals were meta-analysed using random effect models and
were grouped by study-level characteristics.
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Results
Sixty-six observational (23 prospective cohort and 43 retrospective cohort or case-control)
studies with data on 512,508 participants were included. Comparing males to females and
smokers to non-smokers, the pooled RRs for PJI were 1.36 (1.18–1.57) and 1.83 (1.24–
2.70) respectively. There was no evidence of any significant associations of PJI with age
and high alcohol intake. Comparing BMI 30 versus < 30 kg/m2; 35 versus < 35 kg/m2;
and 40 versus < 40 kg/m2; the pooled RRs were 1.60 (1.29–1.99); 1.53 (1.22–1.92); and
3.68 (2.25–6.01) respectively. Histories of diabetes, rheumatoid arthritis, depression, ste-
roid use, and previous joint surgery were also associated with increased risk of PJI. The
results remained similar when grouped by relevant study level characteristics.
Conclusions
Several potentially modifiable patient-related factors are associated with the risk of develop-
ing PJIs. Identifying patients with these risk factors who are due to have arthroplasty surgery
and modulating these risk factors might be essential in reducing the incidence of PJI. Fur-
ther research is however warranted to assess the potential clinical utility of these risk factors
as risk assessment tools for PJI.
Systematic Review Registration
PROSPERO 2015: CRD42015023485
Introduction
Total joint arthroplasty (TJA) is one of the most common elective orthopaedic surgical proce-
dures; it is a highly successful and cost-effective intervention for alleviating pain and disability
associated with advanced joint disease [1–4]. Periprosthetic joint infections (PJIs) are uncom-
mon but devastating and dreaded complications of total joint arthroplasties [5, 6] and can
result in severe pain, functional deficits, poor quality of life, and even death [7–9]. PJIs are
commonly managed using further surgical revisions (debridements, one- or two-stage revision
surgery), which are associated with further risk of re-infection [10], prosthetic complications,
subsequent revisions, repeated hospitalizations, and high costs [11, 12]. With increasing life
expectancy, a growing healthcare burden due to osteoarthritis [13], and a predicted large rise
in the numbers of primary total knee arthroplasties (TKAs) and total hip arthroplasties
(THAs) being performed, there may be a proportionate rise in the number of patients requiring
revision surgery for PJIs in the coming decades [14, 15].
Given the increasing numbers of patients who will be affected by PJIs and their associated
sequelae, which include a high financial burden to health systems [16, 17], it is crucial to
address this issue from a public health perspective. Therefore, there is a need to identify risk
markers or factors for PJI, which can be modulated to mitigate the risk for developing PJIs in
patients. The risk of developing PJI is likely to be influenced by several factors such as charac-
teristics of the patients, the surgical intervention, and post-operative care, but the nature and
magnitude of the relationships are uncertain. Several individual studies have reported on the
associations of a range of patient-, surgical-, and hospital-related risk factors for PJI, but studies
were often poorly powered to adequately quantify the magnitude of the associations. There
Patient-Related Risk Factors and Periprosthetic Joint Infection
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have been efforts to aggregate these data resulting in a number of published reviews on the
topic. In pooled analysis of 14 studies, Kerkhoffs and colleagues reported an odds ratio of 1.90
for overall infection after TKA, comparing obese (body mass index 30 kg/m2) to non-obese
patients [18]. Yuan and colleagues also reported a two-fold increase risk of surgical site infec-
tions for obesity [19]. Kwong and colleagues found no convincing evidence of a relationship
between anticoagulant prophylaxis and PJI in their narrative review [20]. In a meta-analysis of
three studies, Tsang and Gaston found diabetes mellitus (DM) to be associated with a 2.04
increased risk of established surgical site infection after elective THA [21]. In the most recent
review, Zhu and colleagues in pooled analysis of 14 studies, reported several patient- (e.g. body
mass index (BMI), DM, corticosteroid therapy, history of rheumatoid arthritis, malignancy)
surgical- (e.g. presence of wound drain, prolonged operative time) and hospital-related factors
(e.g. National Nosocomial Infections Surveillance Score 2; other nosocomial infection) to be
associated with risk of PJI [22].
In addition to the limited number of studies pooled which did not provide adequate power
to evaluate the associations and the inconclusive results reported by some of these previous
reviews, there were several other features of these reviews which limited the validity of their
findings. First, most of the reviews (apart from that of Zhu and colleagues [22]) focused on a
limited range of potential risk factors, with several of them focusing on obesity [18, 19]. Second,
the majority of previous reviews included studies with short follow-up durations (e.g. 30 or 90
days), which precluded the ability to evaluate the long term associations of potential risk factors
with the occurrence of PJI. In epidemiological observational studies involving a potential risk
factor and an outcome, establishing a long-term association between the risk factor and the
outcome enables the development of early intervention strategies in the course of the disease
process that may influence the outcome. Third, the heterogeneous definition of infection out-
comes by the studies included in these reviews makes interpretation of the findings difficult.
Fourth, none of the previous reviews conducted detailed exploration of potential sources of
heterogeneity among the contributing studies using formal tests such as subgroup and meta-
regression techniques. Fifth, publication bias was not assessed in any of these reviews. Finally,
several relevant individual reports have been published since the publication of these reviews.
With the emerging evidence on the role of patient-related factors such as sociodemographic
characteristics, BMI, and medical and surgical histories in the development of PJI, there is a
need to provide robust evidence on the long-term relationships of these patient factors with
risk of PJI using large-scale longitudinal data. With the exception of factors such as age and
sex, many patient factors are modifiable and could potentially be used in the identification of
patients at high risk of developing PJIs and targeting appropriate interventions. In this context,
our first aim was to comprehensively and reliably assess the long-term ( 1 year follow-up)
prospective associations (nature and magnitude) of a wide range of key patient modifiable fac-
tors with the risk of PJI using a systematic meta-analytic approach. Our second aim was to
address some of the limitations of previous published reviews as reported above. Finally, we
also aimed to assess the associations of these patient-related factors with risk of superficial
wound infections using a systematic meta-analytic approach.
Methods
Data Sources and Search Strategy
This review was conducted using a predefined protocol, which has been registered in the
PROSPERO prospective register of systematic reviews (CRD42015023485). It was also con-
ducted in line with PRISMA (Appendix A in S1 File) and MOOSE guidelines [23, 24] (Appen-
dix B in S1 File). We systematically searched MEDLINE, EMBASE, Web of Science, and
Patient-Related Risk Factors and Periprosthetic Joint Infection
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Cochrane databases from inception up to September 1, 2015. The search strategy combined
search terms related to the exposures (e.g., “risk factor”, “body mass index”, “comorbidity”)
with those related to the outcomes (e.g., “periprosthetic joint infection”, “prosthetic joint infec-
tion”, “deep prosthetic infection”, “deep infection”, “deep surgical site infection”). No restric-
tions were placed on language, an important consideration, given the perceived international
interest in the prevention and management of PJI. The search was complemented by manual
scanning of reference lists of identified articles and relevant review articles. The search was
restricted to studies conducted in humans. Appendix C in S1 File provides more details on the
search strategy.
Eligibility Criteria
Studies were eligible for inclusion if they were longitudinal studies (prospective or retrospective
case-control, prospective cohort, retrospective cohort, case-cohort, nested-case control, or clin-
ical trials) that had reported on the associations of any patient factors such as: (i) sociodemo-
graphic characteristics; (ii) BMI; or (iii) medical and surgical histories with PJI following
primary or revision TJA (THA, TKA, total shoulder arthroplasty, total elbow arthroplasty, or
total ankle arthroplasty), and if they had had at least one year of follow-up (given that a mini-
mum of one-year follow-up after implantation is normally required for PJI surveillance [25–
27]). Due to the variation in the definition of surgical site infection in the included studies, out-
comes were categorised as PJI (periprosthetic joint infection, deep infection, deep surgical site
infection, or deep prosthetic infection) or superficial wound infection. Studies that assessed
these patient-related factors and the risk of superficial wound infection with at least one year of
follow-up were also included in a subsidiary analysis. We excluded studies (i) that assessed the
associations between risk factors and readmissions or revisions due to infection following
arthroplasty; (ii) that were restricted to patients with prevalent diseases (e.g. diabetes, rheuma-
toid arthritis, etc.) and had no comparison or control groups; and (iii) that involved patients
who had undergone hemiarthroplasty.
Data Extraction and Quality Assessment
Two independent authors (S.K.K., A.D.B.) used a standardized data abstraction form to extract
data and performed quality assessments. Discrepancies were discussed and agreement reached
by adjudication of a third author (M.R.W). Information was extracted on study design, publi-
cation year, geographical location, baseline age, proportion of male participants, duration of
follow-up, sample size, type of infection, number of infection outcomes, risk estimates (risk
ratios or hazard ratios for cohort studies and odds ratios for case-control) for fully-adjusted
models when reported, and statistical adjustment for confounders. In the case of multiple pub-
lications involving the same cohort, the most up-to-date study or comprehensive study was
included. We corresponded with study authors to provide additional information. For studies
not published in English, study authors and University colleagues helped translate and inter-
pret the relevant findings. Information on study quality was assessed based on the nine-star
Newcastle—Ottawa Scale (NOS) [28], a validated tool for assessing the quality of non-rando-
mised studies (including cohort and case-control studies), which has been described previously
[29–31]. Briefly, it incorporates information on three pre-defined domains namely: selection of
participants (population representativeness), comparability (adjustment for confounders), and
ascertainment of outcomes of interest. The score varies from zero to a maximum of nine,
which reflects the highest study quality. A score of 5 indicated adequate quality for inclusion
in our review.
Patient-Related Risk Factors and Periprosthetic Joint Infection
PLOS ONE | DOI:10.1371/journal.pone.0150866 March 3, 2016 4 / 18
Statistical Analyses
Relative risks (RRs) with 95% confidence intervals (CIs) were used as summary measures of
associations (risk estimates) across studies. Following Cornfield’s rare disease assumption [32],
hazard ratios, risk ratios, and odds ratios were assumed to approximate the same measure of
RR. Fully-adjusted risk estimates were used when available. Crude RRs were calculated for
studies that reported raw counts. To ensure consistency and enhance comparability and inter-
pretation of the findings, reported study-specific RRs (e.g. per 10 unit change) were trans-
formed to a common scale before pooling where possible, using standard statistical methods
[33]. Due to the different cut-offs used for BMI by the included studies, we employed the
following risk comparisons based on the data available: 25 versus< 25 kg/m2; 30
versus< 30 kg/m2; 35 versus< 35 kg/m2; 40 versus< 40 kg/m2; and per unit increase in
BMI. Random-effects models were pre-specified to pool RRs to minimise the effect of between-
study heterogeneity [34]. When a study reported more than one estimate of the association
between the exposure and outcome (PJI) according to subgroups (e.g., by BMI), a within-study
pooled estimate was calculated using a fixed effect analysis. Heterogeneity was quantified using
the Cochrane χ2 statistic and the I2 statistic [35]. Subgroup and meta-regression [36] analyses
were used to assess several study-level characteristics which might explain heterogeneity,
including geographical location, study design, average baseline age, average duration of follow-
up, type of arthroplasty, number of infection outcomes, degree of adjustment, and study qual-
ity. Evidence of publication bias or small study effects was assessed using funnel plots and
Egger’s regression symmetry tests [37]. We performed a narrative synthesis for studies that
could not be included in the pooled analysis. All statistical tests were two-sided and p-values
of< 0.05 were considered statistically significant. All statistical analyses were performed with
STATA release 14 (Stata Corp, College Station, Texas, USA). The dataset for our analyses can
be found in S2 File.
Results
Study Identification and Selection
The literature search strategy identified 5,383 potentially relevant articles. After the initial
screening of titles and abstracts, 133 articles remained for further evaluation. Following
detailed evaluation which included full text reviews, 67 articles were excluded because (i) fol-
low-up time was not adequate (n = 31); (ii) outcomes were not relevant (n = 16); (iii) exposures
were not relevant (n = 10); (iv) there was inadequate data with no response from authors
(n = 5); and (v) the populations were not relevant (n = 5) (Appendix D in S1 File). The remain-
ing 66 articles corresponding to 66 observational studies met the inclusion criteria and were
included in the review (Fig 1; Table A and Appendix E in S1 File).
Study Characteristics and Study Quality
Table A in S1 File summarizes characteristics and quality assessment scores of the included
studies. Overall, the studies involved 512,508 participants, including 8,026 PJI cases. Twenty-
six studies each were conducted in Europe (UK, France, Italy, Finland, Spain, Netherlands,
Switzerland, Portugal, Belgium, Norway, and Sweden) and North America (USA and Canada);
seven in the Pacific (Australia); and seven in Asia (Japan, Korea, China, Hong Kong, Israel,
and Malaysia). The mean baseline age of participants ranged from 54 to 72 years. All included
studies were observational studies comprising of 23 prospective cohort and 43 retrospective
(cohort or case-control) designs with at least one year of follow-up. The mean follow-up for
infection outcomes ranged from 1 to 17 years. There was some variability in the type of
Patient-Related Risk Factors and Periprosthetic Joint Infection
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arthroplasties, but majority of studies involved THAs and TKAs. Methodological quality of
included studies ranged from 5–8.
Associations of Sociodemographic Characteristics and PJI
The associations of several sociodemographic characteristics with risk of PJI were reported in a
total of 32 studies (Fig 2; Figs A-C in S1 File). Comparing males to females in 28 studies, the
pooled variably adjusted RR (95% CI) for PJI was 1.36 (1.18–1.57). In pooled analysis of eight
studies, smokers had an increased risk of PJI compared to non-smokers RR (95% CI) 1.83
(1.24–2.70). There was no evidence of any statistically significant associations of PJI with age
and high alcohol intake. One study reported a decreased risk of PJI comparing patients in rural
locations versus non-rural locations, RR (95% CI) 0.77 (0.61–0.97). There was evidence of
Fig 1. PRISMA flow diagram.
doi:10.1371/journal.pone.0150866.g001
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substantial between-study heterogeneity in the gender analysis (I2 = 75%; 95% CI 65, 83%;
p< 0.001), which was partly explained by type of arthroplasty (P for meta-regression = 0.015).
Weaker associations were observed in patients with THA compared to studies in patients with
TKA (Fig 3).
Two studies (comprising 27,636 participants and 544 cases) reported on the associations of
gender with risk of superficial wound infection. Comparing males to females, the pooled RR
(95% CI) for superficial wound infection was 0.87 (0.71–1.07).
Associations of BMI and PJI
The associations of BMI categories with risk of PJI were reported in 29 studies. The pooled var-
iably adjusted RR (95% CI) for PJI in a comparison of individuals with a BMI 25 versus< 25
kg/m2 was 1.02 (0.68–1.52). Comparing BMIs 30 versus< 30 kg/m2, 35 versus< 35 kg/
m2, and 40 versus< 40 kg/m2, the pooled RRs (95% CIs) were 1.60 (1.29–1.99), 1.53 (1.22–
1.92), and 3.68 (2.25–6.01) respectively. In pooled analysis of two studies, a unit increase in
BMI was associated with a RR (95% CI) of 1.09 (0.92–1.29) for PJI (Fig 4; Fig D in S1 File).
There was evidence of moderate between-study heterogeneity in the BMI 30 versus< 30
kg/m2 comparison group (I2 = 51%; 95% CI 19, 71%; p = 0.004), which was partly explained by
study level characteristics such as type of arthroplasty (P for meta-regression< 0.0001) and
study quality (P for meta-regression = 0.001) (Fig 5). Stronger associations were observed in
studies that included patients that were treated exclusively by THA or TKA and studies with
higher quality scores.
Fig 2. Sociodemographic characteristics comparisons and risk of periprosthetic joint infection. CI, confidence interval (bars); RR, relative risk; †, are
number of participants or arthroplasties.
doi:10.1371/journal.pone.0150866.g002
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Due to differences in BMI categories, four studies could not be included in the pooled
results for PJI. Comparing BMI 40 versus< 25 kg/m2, one study reported a RR (95% CI) of
6.41 (1.67–24.59) for PJI (Reference 55 of Appendix E in S1 File). Another study reported a RR
(95% CI) of 18.30 (4.25–79.37) comparing BMI 50 versus< 50 kg/m2 (Reference 37 of
Appendix E in S1 File). A further study reported a RR (95% CI) of 3.02 (0.86–10.63) comparing
BMI> 35 versus 35 kg/m2 (Reference 11 of Appendix E in S1 File). One study comparing
underweight (BMI< 18.5 kg/m2) versus normal to overweight BMI category (BMI< 18.5 ver-
sus 18.5–30.0 kg/m2) reported a RR (95% CI) of 2.88 (0.89–9.23) (Reference 52 of Appendix E
in S1 File).
Ten studies reported the associations of BMI categories with risk of superficial wound infec-
tion. In pooled analysis of six studies, the RR (95% CI) for superficial wound infection in a
comparison of individuals with a BMI 30 versus< 30 kg/m2 was 2.78 (1.77–4.35). In pooled
analysis of three studies comparing BMIs 40 versus< 40 kg/m2, the RR was 2.81 (1.44–5.50)
in pooled analysis of three studies (Fig E in S1 File). There was no evidence of heterogeneity
between contributing studies in both analyses. One study could not be included in the pooled
Fig 3. Risk of periprosthetic joint infection comparing males to females, grouped according to several study characteristics. CI, confidence interval
(bars); *, P-value for meta-regression; †, are number of participants or arthroplasties; ‡, number of cases and participants do not add up to total because of
missing data; PJI, periprosthetic joint infection; THA, total hip arthroplasty; TKA, total knee arthroplasty.
doi:10.1371/journal.pone.0150866.g003
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analysis. In this study, a RR (95% CI) of 9.89 (1.03–94.82) for superficial wound infection com-
paring BMI> 35 versus 35 kg/m2 was reported (Reference 11 of Appendix E in S1 File).
Medical and Surgical Histories and Risk of PJI
Forty-two studies reported on the associations between several medical and surgical history
characteristics with risk of PJI. Comparing patients with histories of diabetes versus no diabe-
tes, rheumatoid arthritis versus no rheumatoid arthritis, and depression versus no depression,
the pooled variably adjusted RRs (95% CIs) for PJI were 1.74 (1.45–2.09), 1.70 (1.37–2.11), and
1.48 (1.13–1.95) respectively. Patients with a history of steroid administration versus no history
of steroid administration and previous joint surgery versus no previous joint surgery had an
increased risk of PJI, RRs (95% CIs) 1.68 (1.26–2.25) and 2.98 (1.49–5.93) respectively. Patients
who had a revision arthroplasty had an increased risk of PJI compared to those who had a pri-
mary arthroplasty, RR (95% CI) 2.26 (1.30–3.92). There was no evidence of any statistically sig-
nificant associations of PJI with histories of osteoarthritis, osteonecrosis, post-traumatic
arthritis, cardiovascular disease (CVD), hypertension, and cancer. Use of intra-articular steroid
injection was also not statistically significantly associated with an increased risk of PJI (Fig 6;
Figs F-K in S1 File). Two studies could not be included in the pooled analysis. In one study,
there was an increased risk of PJI comparing frail patients to non-frail patients, RR (95% CI)
1.64 (1.28–2.11) (Reference 62 of Appendix E in S1 File). In another, the authors reported no
Fig 4. Bodymass index comparisons and risk of periprosthetic joint infection.CI, confidence interval (bars); RR, relative risk; †, are number of
participants or arthroplasties.
doi:10.1371/journal.pone.0150866.g004
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evidence of any statistically significant associations of PJI with low- or high-risk dental proce-
dures (Reference 39 of Appendix E in S1 File). There was evidence of substantial between-
study heterogeneity in the diabetes analysis (I2 = 72%; 95% CI 59, 81%; p< 0.001), which was
partly explained by event rate for PJI (P for meta-regression = 0.015). Stronger associations
were observed in studies with< 50 cases compared to studies with 50 cases (Fig L in S1 File).
Seven studies reported on the associations of diabetes status, previous joint surgery, and use
of intra-articular steroid injection with risk of superficial wound infection. In patients with dia-
betes compared with those with no diabetes, the RR (95% CI) for superficial wound infection
in pooled analysis of three studies (2,020 participants and 61 cases) was 2.57 (1.07–6.17). There
was no statistically significant evidence of any associations with previous joint surgery and use
of intra-articular steroid injection. There was no evidence of heterogeneity between contribut-
ing studies in these analyses.
Publication Bias
Funnel plots for all analyses that involved five or more studies were all symmetrical under visual
examination, with the exception of studies that evaluated associations of PJI with diabetes status.
Fig 5. Risk of periprosthetic joint infection in bodymass index comparison group 30 versus < 30 kg/m2, grouped according to several study
characteristics. CI, confidence interval (bars); *, P-value for meta-regression; PJI, periprosthetic joint infection; THA, total hip arthroplasty; TKA, total knee
arthroplasty; TSA, total shoulder arthroplasty; †, are number of participants or arthroplasties.
doi:10.1371/journal.pone.0150866.g005
Patient-Related Risk Factors and Periprosthetic Joint Infection
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The results were consistent with Egger’s regression tests showing little evidence of publication
bias for all analyses except for diabetes status and PJI (Fig M in S1 File).
Discussion
Key Findings
In a single comprehensive investigation, we have systematically reviewed and summarised
through a meta-analytical approach, available observational longitudinal studies that have
assessed associations of several patient-related (sociodemographic factors, BMI, and medical
and surgical histories) characteristics with risk of PJI. For sociodemographic characteristics,
our results showed an increased risk of PJI in males compared to females and in smokers com-
pared to non-smokers. There was however no statistically significant association of age or high
alcohol intake with risk of PJI. One study reported a decreased risk of PJI comparing patients
in rural locations to those in non-rural locations. For BMI, consistently statistically significant
positive associations were demonstrated for BMI comparisons that involved cut-offs of> 30
kg/m2 or higher. One study that compared underweight versus normal to overweight BMI cat-
egory, reported a trend towards increased risk of PJI for the underweight category, but the esti-
mate was imprecise and not statistically significant. In the analyses of medical and surgical
histories; diabetes, rheumatoid arthritis, depression, history of steroid administration, and pre-
vious joint surgery were each found to be associated with an increased risk of PJI after THA or
TKA. One study reported an increased risk of PJI after TKA in frail compared with non-frail
patients.[38] There was no evidence of any statistically significant associations of PJI with
Fig 6. Medical and surgical history comparisons and risk of periprosthetic joint infection. CI, confidence interval (bars); RR, relative risk; †, are
number of participants or arthroplasties.
doi:10.1371/journal.pone.0150866.g006
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histories of osteoarthritis, osteonecrosis, post-traumatic arthritis, CVD, hypertension, cancer,
and use of intra-articular steroid injection.
In the subsidiary analyses of patient-related risk factors and superficial wound infection,
only BMI ( 30 kg/m2) and history of diabetes were found to be associated with the risk of
superficial wound infection.
Comparison with Previous Work
Some of our findings concur generally with that of previous reviews on the topic. We also pro-
vide several relevant findings that have not been previously addressed. Our findings of an
increased risk of PJI comparing obese to non-obese patients concurs with previous work on the
topic [18, 19]. However, we have also demonstrated this using several BMI categories and also
reported on the associations with superficial wound infection. In contrast to the reviews by
Tsang and Gaston [21] and Zhu and colleagues [22] which reported DM to be associated with
an increased risk of PJI in pooled analysis of up to eight studies, we demonstrated this associa-
tion in 29 studies and robustly showed that the risk of PJI remained broadly similar across sev-
eral clinically relevant subgroups. Chen and colleagues in a meta-analysis of 12 cohort or case-
control studies involving 548 PJIs, reported several patient-related factors such as male gender,
BMI> 30 kg/m2, diabetes, osteoarthritis, hypertension, steroid therapy, and RA to be associ-
ated with deep infection [39]. We found no association of PJI with osteoarthritis and hyperten-
sion. Similar to our findings, they also showed that age was not associated with the risk of PJI.
In the recent elegant review by Zhu and colleagues [22], in addition to a number of patient-
related factors (such as hypoalbuminaemia, immunodepression, and coagulopathy) which
were observed to be associated with PJI, the authors also evaluated the associations of several
surgical- and hospital-related factors with the risk of PJI. In agreement with their findings,
BMI, DM, steroid therapy, history of rheumatoid arthritis, and previous surgery were found to
be associated with risk of PJI; whiles no associations were demonstrated for high alcohol intake,
hypertension, and CVD. However, despite the wide-ranging array of potential risk factors eval-
uated, the meta-analysis was based on only 14 studies retrieved from multiple databases span-
ning 1980–2014, with majority of the associations based on pooled analysis of 2–3 studies. In
addition, in contrast to the approach employed by these previous reviews, we assessed the
long-term associations (follow-up duration of 1 year) between these factors and the risk of
PJI. We also conducted subgroup analyses by relevant study level characteristics. In our analy-
ses comparing males to females, the risk of PJI remained broadly similar across several clini-
cally relevant subgroups. However, stronger associations were observed in studies that
included patients with a combination of THA and TKA compared to patients treated exclu-
sively by THA or TKA. Comparing BMI 30 versus< 30 kg/m2 (which had the highest num-
ber of studies in this comparison), the risk of PJI remained broadly similar across several
clinically relevant subgroups.
Possible Explanations for Findings
A number of postulated mechanisms have been postulated for some of the associations demon-
strated. Patient-related factors that are known to be causally related to PJI include male sex
and previous joint surgery [40]. Smoking has been suggested to contribute to PJI by delaying
wound healing through nicotine-mediated vasoconstriction [41, 42]. A sluggish circulation
causes tissue hypoxia with increased susceptibility to infection [40]. In addition, smoking
causes endothelial dysfunction, inflammation, progression of atherothrombosis, and impaired
systemic immune response, which are known to contribute to poor wound healing and subse-
quently to infection. High alcohol intake, similar to smoking, is known to lead to higher
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postoperative complications including PJI. We were unable to demonstrate this in our study,
possibly due to the low power to detect an effect in our analysis (two studies), evidenced by our
imprecise estimate. Obesity (BMI> 30 kg/m2) has consistently been recognized as an indepen-
dent risk factor for PJI. Suggested underlying factors for this increased risk include long opera-
tive times and presence of additional comorbidities [43, 44]. Obese people are also known to
have impaired tissue antibiotic penetration [45]. One study included in our review suggested
an association between low BMI and increased risk of PJI, which may be due to underlying
poor nutritional status and impaired immunity [46]. The association between diabetes and PJI
may be mediated by impaired leukocyte function and microvascular complications [47], which
may impair wound healing. In addition, factors associated with diabetes, such as hyperglyce-
mia, hyperlipidemia, hypertension, and increased oxidative stress, upregulate cellular and
inflammatory reactions and play a part in atherothrombosis [48], which also cause impaired
wound healing. Hyperglycemia, has also been shown to increase biofilm formation [49], which
may cause an increased risk of PJI. Given that there is a genetic predisposition to PJI [50],
whether some of these associations have any causal relevance may need to be confirmed in
appropriate interventional studies or Mendelian randomization studies [51].
Implications of Our Findings
Our results are very relevant and offer new insight concerning the relationships between several
patient-related risk factors and PJI risk. The findings may also have implications for the pre-
vention of PJI after total joint arthroplasty. Given the challenging complication of PJI and its
major burden for patients [9] and health systems [52], prevention through implementation of
effective strategies is the first and best strategy and should be a priority. Therefore, identifying,
mitigating, and optimising amenable risk factors for PJI is a highly desirable approach for pre-
vention. Our findings show that multiple potential modifiable patient-related factors such as
smoking, BMI 30 kg/m2, diabetes, depression, steroid use, and frailty are significantly associ-
ated with long-term risk of PJI. Identifying patients with these risk factors who are due to have
arthroplasty surgery and providing interventions to modify these risk factors might form the
basis of PJI prevention strategies. For example, it has been established that smoking cessation
before surgery is associated with more than 50% decreased risk of postoperative infections
[53]. Indeed, some centers in line with US Centers for Disease Control and Prevention (CDC)
recommendations [26], enrol smokers in a cessation program and instruct them to abstain
from smoking for at least 30 days before elective arthroplasty [54]. Randomized controlled tri-
als are also warranted to investigate the potential implications.
Study Strengths and Limitations
The current study has several advantages compared to previous reviews. Given the inclusion of
several recent published reports on the topic, it is an updated assessment of the topic. Our
search strategy was comprehensive, was without language restriction, and spanned multiple
databases, yielding 66 published reports on the topic, making it the largest review on the topic
to date. Compared to previous reviews, we had enhanced power to examine the associations of
multiple patient-related factors with risk of PJI, as well as superficial wound infection in greater
detail. We only included studies with at least one year follow-up for infection outcomes, reli-
ably indicating long-term associations between these factors and risk of PJI. Our results were
robust as we were able to standardize and harmonize reported associations (to a common
scale) from almost all contributing studies before pooling, thereby quantifying more reliably
the magnitude of the associations between several risk factors and PJI. We also conducted
detailed subgroup analyses using a range of several study-level and clinically relevant
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characteristics to explore potential sources of heterogeneity. Formal tests including subgroup
analysis by study size, were unable to detect publication bias for a majority of the analyses. The
limitations of the present review also merit careful consideration. First, due to lack of a stan-
dard definition of PJI in included studies, it was not possible to attain a consistent definition
across all studies. We however conducted a detailed assessment using a validated tool for
assessing the quality of non-randomised studies, to provide an unbiased assessment of PJI out-
comes. Second, we pooled estimates from both retrospective and prospective cohort designs,
which could have potentially led to biased estimates. However, subgroup analyses according to
the type of study design showed generally similar associations. Third, we were unable to test
for the dose-response shapes of the associations between patient-related risk factors (such as
BMI) and PJI. Fourth, there was evidence of substantial heterogeneity among contributing
studies for some analyses, however we systematically investigated for possible sources of het-
erogeneity using several subgroup and meta-regression analyses. Fifth, as the present review
was based on variably adjusted data reported by the eligible studies, there remained a risk of
residual confounding. However, subgroup group analyses in relevant comparisons showed
similar risks of PJI between unadjusted and multivariate-adjusted data. Sixth, majority of stud-
ies reported on PJI following TJA and did not make a distinction between THA and TKA, how-
ever, our subgroup analyses explored the associations for this distinct groups where adequate
data allowed. Seventh, majority of studies also failed to make a distinction between primary
and revision TJA, however, we were able to assess the associations comparing patients who had
a revision arthroplasty versus those who had a primary arthroplasty. Eight, it was not clear
from majority of included studies that “history of steroid administration” included a combina-
tion of oral steroid administration and use of intra-articular steroid injection. However, we
were able to pool estimates from three studies based on use of intra-articular steroid injection.
Finally, we were unable to evaluate the associations of diabetes-related (e.g. duration and sever-
ity of diabetes) and smoking-related (e.g. frequency of smoking) factors on the risk of PJI given
the sparse data available. In one of the included studies, Moon and colleagues demonstrated
that the duration of diabetes and the number of complications of diabetes did not influence the
risk of PJI [55]. Further studies are warranted to evaluate the associations of these related fac-
tors with risk of PJI. Given the several limitations of aggregate data, access to individual partici-
pant data should enable a consistent definition of PJI outcomes and a detailed assessment of
several aspects of the associations such as characterisation of the shape of any dose-response
relationships, consistent adjustment for covariates across studies, assessment of the associa-
tions in different subgroups, and the usefulness of patient-related risk factors in PJI risk predic-
tion. The findings should therefore be interpreted in context of the limitations described.
Conclusions
Evidence from aggregate published data suggests that several potential amenable patient-
related factors such as smoking, BMI 30 kg/m2; diabetes, depression, steroid use, and frailty
are associated with long-term risk of developing PJIs. Identifying patients with these risk fac-
tors who are due to have arthroplasty surgery and modulating these risk factors might be essen-
tial in reducing the incidence of PJI. Further research is however warranted to assess the
potential clinical utility of these risk factors as risk assessment tools for PJI.
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